Anne Samuel
Stock Analyst at JP Morgan
(3.24)
# 1,021
Out of 4,944 analysts
67
Total ratings
52.38%
Success rate
1.71%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $63.56 | -5.60% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $190.40 | -7.04% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $31.18 | +15.46% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $278.86 | -10.71% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $9.44 | +27.12% | 12 | Mar 10, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $22.53 | +2.09% | 7 | Jan 28, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $28.36 | -1.27% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $24.53 | -22.54% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $27.08 | -22.45% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $3.23 | +302.48% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $35.37 | -23.66% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $3.94 | +26.90% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $89.15 | +21.14% | 8 | Apr 2, 2024 |
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $63.56
Upside: -5.60%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $190.40
Upside: -7.04%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $31.18
Upside: +15.46%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $278.86
Upside: -10.71%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $9.44
Upside: +27.12%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $22.53
Upside: +2.09%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $28.36
Upside: -1.27%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $24.53
Upside: -22.54%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $27.08
Upside: -22.45%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $3.23
Upside: +302.48%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $35.37
Upside: -23.66%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $3.94
Upside: +26.90%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $89.15
Upside: +21.14%